Changes in the wind for Respiratory Brand

Quote

anonymous

Guest
Wheels are in motion at home office for a potential downsizing in respiratory over the next 9 to 12 months. As PRC continues to fall further from projected numbers and with generic Pro-Air on the horizon (it is not being delayed to the extant that you are being told), steps are being taken to prep for a culling of the sales force. Extensive background checks are being done on all reps at a level not seen before. They are looking for anything that could be used to terminate a rep and avoid layoff packages later and back filling (if needed) with younger less expensive reps. Managers are under the highest pressure in years to push out any rep with poor goal attainment even if the goals are the problem not the rep. Teva is finally waking up to the fact that our next big product (Advair in a Respiclick device) will be up against a generic version around the same time as launch. I has been a good run here but unless we buy a ready to market product that is not another "me-too" entry, our days are numbered. This is simple math...they can't keep paying all of our costs without new revenue to replace our aging products. I wrote this post with the intent to give you a peek behind the curtain at Home office. This way you can make the necessary adjustments in financial planning should you be displaced later. This layoff is not a foregone conclusion but the odds are high that it will happen unless Teva pulls a rabbit out of their hat.

Best of luck to all.
 

Background checks like never before? This has been TC's MO for a couple of years now. Look at the dumpster fire in ATL. A couple of years ago he fired most over two days of phone calls and shafted a few out of big bonuses. If reps in this division have not seen the writing on the wall by now and are not very actively looking, well may they go down with the ship.
 
This is already in progress... ten regions have been tasked with re-launching PRC for the third time. We have been told to pick at least 10 targets and hyper-focus on them AGAIN!(as if we weren't already begging and pleading from all of them) This time with new tracing sheets that go through the end of December 2016. We are being told that that if we are not at the national average by the end of the year we will be put on a plan if not already on one. This plan will be progressive if we do not improve numbers/goal attainment once it is started. What drives my crazy is that we just lost coverage of our largest insurance plan on August 1st (one of the very few we even had) and we are being told to just make it up elsewhere while also increasing our numbers to get within striking distance of the ridiculous goals. My manager said that an animated phone call took place with CC about PRC numbers and he was not wanting to hear any of the valid reasons as to why this was happening. I agree with your guess around the timing of the layoff, it fits with what many of us are going through now.


anonymous said:
Wheels are in motion at home office for a potential downsizing in respiratory over the next 9 to 12 months. As PRC continues to fall further from projected numbers and with generic Pro-Air on the horizon (it is not being delayed to the extant that you are being told), steps are being taken to prep for a culling of the sales force. Extensive background checks are being done on all reps at a level not seen before. They are looking for anything that could be used to terminate a rep and avoid layoff packages later and back filling (if needed) with younger less expensive reps. Managers are under the highest pressure in years to push out any rep with poor goal attainment even if the goals are the problem not the rep. Teva is finally waking up to the fact that our next big product (Advair in a Respiclick device) will be up against a generic version around the same time as launch. I has been a good run here but unless we buy a ready to market product that is not another "me-too" entry, our days are numbered. This is simple math...they can't keep paying all of our costs without new revenue to replace our aging products. I wrote this post with the intent to give you a peek behind the curtain at Home office. This way you can make the necessary adjustments in financial planning should you be displaced later. This layoff is not a foregone conclusion but the odds are high that it will happen unless Teva pulls a rabbit out of their hat.

Best of luck to all.
Click to expand...
 
If you have not seen this coming then you have not been paying attention. Launching a me 3 FP and a me 4 combo is no way to keep a ship afloat. Crapamazalab the infusion buy and bill nightmare is a biological anchor that will be one of the final nails in the coffin.
Just hold on, give them no ammo and wait for the package.
 
anonymous said:
Wheels are in motion at home office for a potential downsizing in respiratory over the next 9 to 12 months. As PRC continues to fall further from projected numbers and with generic Pro-Air on the horizon (it is not being delayed to the extant that you are being told), steps are being taken to prep for a culling of the sales force. Extensive background checks are being done on all reps at a level not seen before. They are looking for anything that could be used to terminate a rep and avoid layoff packages later and back filling (if needed) with younger less expensive reps. Managers are under the highest pressure in years to push out any rep with poor goal attainment even if the goals are the problem not the rep. Teva is finally waking up to the fact that our next big product (Advair in a Respiclick device) will be up against a generic version around the same time as launch. I has been a good run here but unless we buy a ready to market product that is not another "me-too" entry, our days are numbered. This is simple math...they can't keep paying all of our costs without new revenue to replace our aging products. I wrote this post with the intent to give you a peek behind the curtain at Home office. This way you can make the necessary adjustments in financial planning should you be displaced later. This layoff is not a foregone conclusion but the odds are high that it will happen unless Teva pulls a rabbit out of their hat.

Best of luck to all.
Click to expand...

Why would they continue to hire then? We are spread so thin as it is. Other companies, like GSK, have 5 reps to our 1 rep. We have new products coming out. This doesn't seem very logical to me.
 
I would be interviewing employment attorneys if they start firing people to avoid laying them off. Firing reps for numbers when all else is good deserves a call to the FDA.
 
TC just struck again. How dare you question a Custer decision, mule skinner!
 
anonymous said:
I would be interviewing employment attorneys if they start firing people to avoid laying them off. Firing reps for numbers when all else is good deserves a call to the FDA.
Click to expand...
Uhh they have been doing this in the central south ever since "Xanadu" took over. A lot of bonus $$ left at Teva while senior reps were let go. It wasn't for #s either. TC and LM headhunted older reps and even minorities.
 
anonymous said:
The company is still doing well, even though we aren't with RC. Qvar and HFA can sustain us while we work on RC and the new products. I call BS on this thread.
Click to expand...

You must be from HR or another HO troll (or Kool-aid drinking rep). Anyone working here knows that we are completely choking on our numbers for RC. To your other comments, Pro Air-HFA goes generic in December, and yes, a generic is on the horizon contrary to what we are being told. Currently, Pro Air-HFA is by far the biggest contributor to our bottom line so any changes on its revenue stream will have dramatic effects. Qvar is doing Ok but that is now threatened as HFA (owned by 3M) loses its patent early next year, opening the door for cheap generics to enter the market with an "HFA" product. Keep in mind that Beclomethasone has been generic for years and the only hold back to generics was the patent on the HFA ingredient. Our next product in line is an "RC" version of Advair due to come out at the same time a generic Advair hits the market. Now take a guess which one the insurance is going to cover... the branded "RC" version or the much less expensive generic?
 
Seems Wall street is catching on to Teva's woes . Today stock just dropped to lowest point since October 2013.

anonymous said:
You must be from HR or another HO troll (or Kool-aid drinking rep). Anyone working here knows that we are completely choking on our numbers for RC. To your other comments, Pro Air-HFA goes generic in December, and yes, a generic is on the horizon contrary to what we are being told. Currently, Pro Air-HFA is by far the biggest contributor to our bottom line so any changes on its revenue stream will have dramatic effects. Qvar is doing Ok but that is now threatened as HFA (owned by 3M) loses its patent early next year, opening the door for cheap generics to enter the market with an "HFA" product. Keep in mind that Beclomethasone has been generic for years and the only hold back to generics was the patent on the HFA ingredient. Our next product in line is an "RC" version of Advair due to come out at the same time a generic Advair hits the market. Now take a guess which one the insurance is going to cover... the branded "RC" version or the much less expensive generic?
Click to expand...
 
So the east coast is doing another relaunch on ProAIR RC with new manager. We have nothing to worry about. The POA in Nashville will bring great enthusiasm to hit it hard this season and use all the free vouchers that we no longer have but you'll get paid more to hit higher number of scripts - especially for the pediatric population! Don't worry that 50-80% of ped patients are Medicaid. This is not selling - it's begging- to switch patients based on new device not new drug and it's not working! Be ready for 1- when is this going generic and 2- where's the study that it IS more effective than HFA?..well Teva doesn't want to lose HFA sales - no commission to pay out!
 


Write your reply...
Top Bottom
Back
Quote